Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tuberculin Conversion Following BCG Vaccine Vial (Bio Farma) Compared to Registered BCG Vaccine (Bio Farma) in Indonesian Infants

NCT05124340 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.

NCT NCT05124340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05124340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tuberculin Conversion Following BCG Vaccine Vial (Bio Farma) Compared to Registered BCG Vaccine (Bio Farma) in Indonesian Infants
Lead sponsor
PT Bio Farma
Phase
Phase 2
Overall status
Completed
Start date
December 1, 2021
Completion date
July 30, 2022
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bcg vaccination reaction